Title : Rituxan immunotherapy and zevalin radioimmunotherapy in the treatment of non-Hodgkin's lymphoma.

Pub. Date : 2003 Aug

PMID : 14529425






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Radioimmunotherapy with the rituximab and ibritumomab tiuxetan (Zevalin) regimen was recently approved for the treatment of relapsed or refractory low-grade, follicular or CD20+ transformed NHL, including rituximab refractory follicular NHL. ibritumomab tiuxetan keratin 20 Homo sapiens